Preliminary Program: Friday, June 16, 2023

Presenations will have incorporate a min of 25% interactions btw panel, presenter and audience – through Q&A, polls and or debates.

700 Poster Viewing and Breakfast (networking) and (voting)

Session 1: The Patient Voice – surviving breast cancer (focus on survivorship)
900 Welcome Remarks (Co-Chairs)
Drs. Christine Brezden-Masley and Tulin Cil
905 Patient Voice – Living with metastatic breast cancer
Rethink Breast Cancer

Session 2: Optimization Strategies for Individual Based Prognostic Factors
920 Clinical Case: 41F; 3 cm positive lateral-superior margin; 2/4 LN with ENE Grade 3, HR+/HER2-) panel discussion – pathologist) (5 min) – use of therapy with surgery
925 Medical oncology (systemic therapy/NAT?, duration of ET) (15 min)
940 Surgical oncology (management of the axilla; “near positive margins”) (15 min)
955 Radiation oncology (“near positive margins”; axilla) (15 min)
1010 Discussion Q&A with panel (15 min)
1025 Break and Networking

Session 3: Toxicity management of novel therapeutics (in combination with surgery/radiation)
1040 ADCs (15 min)
1055 Immunotherapy with surgical and radiation planning (15 min)
1110 Cardio-oncology (new ESC guidelines) (15 min)
1125 Lymphedema (post radiation/surgery) (15 min)
1140 Discussion Q&A (20 min)

Session 4: Best Poster Presentations (10 min each): 5 slides

Moderator Amanda Roberts
1200 Top 3 People’s Choice Award (voted) Abstract Submissions – Oral (30 min total)
1230 People’s Choice Award and panel Q&A
12:45 Lunch and Networking

Concurrent Sessions: Surgical Afternoon & Primary Care Physician Afternoon

Concurrent I: Primary Care Physicians
1345 Radiology Screening 101: Imaging Updates: (breast density, tomosynthesis, when ultrasound is needed etc)
1415 Survivorship and Surveillance
Clinical Case (5 minutes)
1420 Sexual health and gynecological symptoms of menopause (20 min)
1440 Lymphedema & Brain Fog (15 min)
1500 Surveillance and Bone Health while on ET (20 min)
1520 Microbiome/Diet/Fasting (15 min)
1535 Exercise and Breast Cancer (15 min)
1550 Panel Discussion (10 min)
1600 Closing Remarks and Evaluations
1610 End of Session

Concurrent II Surgical Oncology
1345 Update on Benign, High Risk and Phyllodes tumors [15min]
1400 Expanded genetic testing – mainstream, rapid genetics study [15min]
1415 Surgical options for prevention and treatment of lymphedema
1430 Panel Discussion (15 min)
1445 Immediate Breast Reconstruction- DTI and Pre-pectoral Implants (20 min)
1505 Flat aesthetic closure and expanded criteria for nipple sparing mastectomy
1520 What’s new in Oncoplastic Surgery
1535 Panel Discussion (15 min)
1550 Closing Remarks and Evaluations
1600 End of Session